ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,170, issued on April 22, was assigned to StarkAge Therapeutics (Lille, France).

"Senescent cell-associated antigen-binding domains, antibodies and chimeric antigen receptors comprising the same, and uses thereof" was invented by Muge Ogrunc (Paris) and Thierry Mathieu (Brussels).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are senescent cell-associated antigen-binding domain and related antibodies and related chimeric antigen receptors. In addition, disclosed are DPP4-binding domains and related antibodies and related chimeric antigen receptors. Also disclosed are methods for treating, preventing or alleviating senescence-related diseases ...